Oakland, CA, United States of America

Gregory L Pattison


Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2001-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gregory L Pattison: Innovator in Protein Formulation

Introduction

Gregory L Pattison is a notable inventor based in Oakland, CA, who has made significant contributions to the field of protein formulation. With a total of four patents to his name, Pattison's work focuses on the solubilization, purification, and refolding of proteins, particularly in the context of therapeutic applications.

Latest Patents

Pattison's latest patents include innovative methods and compositions for formulating tissue factor pathway inhibitor (TFPI). One of his patents describes compositions that facilitate the preparation of pharmaceutically acceptable TFPI at various concentrations. Another patent outlines a method of modifying protein solubility using polyionic polymers, which aids in the solubilization, formulation, purification, and refolding of proteins, especially those that are incorrectly folded or aggregated. These compositions allow for the preparation of TFPI at concentrations exceeding 0.2 mg/mL and even above 10 mg/mL.

Career Highlights

Throughout his career, Gregory L Pattison has worked with various organizations, including G.D. Searle LLC, where he has applied his expertise in protein formulation. His innovative approaches have contributed to advancements in pharmaceutical formulations, enhancing the efficacy of therapeutic proteins.

Collaborations

Pattison has collaborated with notable professionals in his field, including Glenn J Dorin and Bo H Arve. These collaborations have further enriched his research and development efforts, leading to impactful innovations in protein science.

Conclusion

Gregory L Pattison's work in protein formulation and his innovative patents have made a significant impact in the field of biopharmaceuticals. His contributions continue to influence the development of effective therapeutic proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…